Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system
- PMID: 22890969
- DOI: 10.1007/s11060-012-0953-x
Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system
Abstract
Adult grade II low-grade gliomas (LGG) are classified according to the WHO as astrocytomas, oligodendrogliomas or mixed gliomas. TP53 mutations and 1p19q codeletion are the main molecular abnormalities recorded, respectively, in astrocytomas and oligodendrogliomas and in mixed gliomas. Although IDH mutations (IDH1 or IDH2) are recorded in up to 85 % of low-grade gliomas, IDH negative gliomas do occur. We have searched for p53 expression, 1p19q codeletion and IDH status (immunohistochemical detection of the common R132H IDH1 mutation and IDH direct sequencing). Internexin alpha (INA) expression previously recorded to be associated with 1p19q codeletion (1p19q+) gliomas was also analysed. Low-grade gliomas were accurately classified into four groups: group 1, IDH+/p53-/1p19q-; group 2, IDH+/p53-/1p19q+; group 3, IDH+/p53+/1p19q-; and group 4, triple negative gliomas. In contrast to the WHO classification, this molecular classification predicts overall survival on uni- and multivariate analysis (P = 0.001 and P = 0.007, respectively). Group 4 carries the worst prognosis and group 2 the best. Interestingly, p53 +/INA- expression predicts lack of 1p19q codeletion (specificity 100 %, VPP 100 %). The combined use of these three molecular markers allow for an accurate prediction of survival in LGG. These findings could significantly modify LGG classification and may represent a new tool to guide patient-tailored therapy. Moreover, immunohistochemical detection of p53, INA and mR132H IDH1 expression could represent an interesting prescreening test to be performed before 1p19q codeletion, IDH1 minor mutation and IDH2 mutation detection.
Similar articles
-
Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.Eur J Cancer. 2011 Mar;47(5):802-8. doi: 10.1016/j.ejca.2010.11.031. Epub 2010 Dec 29. Eur J Cancer. 2011. PMID: 21194923
-
Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers.Rev Neurol (Paris). 2011 Oct;167(10):683-90. doi: 10.1016/j.neurol.2011.07.006. Epub 2011 Sep 1. Rev Neurol (Paris). 2011. PMID: 21889777 Review.
-
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.Acta Neuropathol Commun. 2015 Dec 23;3:88. doi: 10.1186/s40478-015-0265-4. Acta Neuropathol Commun. 2015. PMID: 26699864 Free PMC article.
-
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria.J Neurooncol. 2017 Nov;135(2):245-254. doi: 10.1007/s11060-017-2571-0. Epub 2017 Jul 26. J Neurooncol. 2017. PMID: 28748342
-
Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review.AJNR Am J Neuroradiol. 2021 Jan;42(1):94-101. doi: 10.3174/ajnr.A6875. Epub 2020 Nov 26. AJNR Am J Neuroradiol. 2021. PMID: 33243896 Free PMC article.
Cited by
-
Pathology and genetics of diffuse gliomas in adults.Neurol Med Chir (Tokyo). 2015;55(1):28-37. doi: 10.2176/nmc.ra.2014-0229. Epub 2014 Dec 20. Neurol Med Chir (Tokyo). 2015. PMID: 25744348 Free PMC article. Review.
-
Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas.Arch Pathol Lab Med. 2022 May 1;146(5):547-574. doi: 10.5858/arpa.2021-0295-CP. Arch Pathol Lab Med. 2022. PMID: 35175291 Free PMC article.
-
Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.Neuro Oncol. 2014 Dec;16(12):1570-4. doi: 10.1093/neuonc/nou297. Epub 2014 Oct 29. Neuro Oncol. 2014. PMID: 25355680 Free PMC article. Review.
-
Atypical nodular astrocytosis in simian immunodeficiency virus-infected rhesus macaques (Macaca mulatta).J Med Primatol. 2014 Dec;43(6):468-76. doi: 10.1111/jmp.12138. Epub 2014 Aug 1. J Med Primatol. 2014. PMID: 25082291 Free PMC article.
-
Machine Learning Versus Logistic Regression Methods for 2-Year Mortality Prognostication in a Small, Heterogeneous Glioma Database.World Neurosurg X. 2019 Jan 24;2:100012. doi: 10.1016/j.wnsx.2019.100012. eCollection 2019 Apr. World Neurosurg X. 2019. PMID: 31218287 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous